Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
4.250
-0.030 (-0.70%)
At close: Oct 29, 2024, 4:00 PM
4.338
+0.088 (2.06%)
After-hours: Oct 29, 2024, 6:19 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $23.09 million as of October 29, 2024. Its market cap has increased by 17.19% in one year.
Market Cap
23.09M
Enterprise Value
-4.30M
1-Year Change
17.19%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since October 3, 2019, Aprea Therapeutics's market cap has decreased from $393.80M to $23.09M, a decrease of -94.14%. That is a compound annual growth rate of -42.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 23.20M | 31.82% |
| Dec 29, 2023 | 17.60M | 0.57% |
| Dec 30, 2022 | 17.50M | -71.59% |
| Dec 31, 2021 | 61.60M | -40.88% |
| Dec 31, 2020 | 104.20M | -89.18% |
| Dec 31, 2019 | 963.30M | 144.62% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pluri | 23.63M |
| Unity Biotechnology | 23.59M |
| RenovoRx | 23.51M |
| Nexalin Technology | 23.29M |
| PolyPid | 23.26M |
| Impact BioMedical | 23.00M |
| BioVie | 22.76M |
| Cadrenal Therapeutics | 22.59M |